← Back to Search

ProDentis Lozenge for Oral Neoplasms

N/A
Waitlist Available
Led By David Drake, MS, PhD
Research Sponsored by University of Iowa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights

Study Summary

This trial is investigating how changes in the types of bacteria in the mouth may be related to the most common type of oral cancer, and whether a probiotic regimen may help prevent or rectify these changes.

Eligible Conditions
  • Oral Cancers

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assessment of changes in the oral microbiome composition over time
Determine the Effect of ProDentis on the Oral Microbiome

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Probiotic LozengeExperimental Treatment1 Intervention
Group II: Placebo LozengePlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ProDentis Lozenge
2022
N/A
~20

Find a Location

Who is running the clinical trial?

University of IowaLead Sponsor
446 Previous Clinical Trials
879,482 Total Patients Enrolled
David Drake, MS, PhDPrincipal InvestigatorUniversity of Iowa College of Dentistry

Media Library

ProDentis Lozenge Clinical Trial Eligibility Overview. Trial Name: NCT04925700 — N/A
Oral Cancers Research Study Groups: Placebo Lozenge, Probiotic Lozenge
Oral Cancers Clinical Trial 2023: ProDentis Lozenge Highlights & Side Effects. Trial Name: NCT04925700 — N/A
ProDentis Lozenge 2023 Treatment Timeline for Medical Study. Trial Name: NCT04925700 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities available for participants in this experiment?

"According to the clinicaltrials.gov website, this research initiative is currently recruiting participants. It was posted on April 20th 2022 and its most recent update took place in August 4th of the same year."

Answered by AI

Does the study accept participants who have surpassed 35 years of age?

"According to the criteria for enrolment, this medical trial requires participants of legal age or older and no more than 89 years old."

Answered by AI

How many individuals are currently engaged in this experiment?

"Affirmative. According to the clinicaltrials.gov website, recruitment for this trial began on April 20th 2022 and was last updated on August 4th 2022. This study is looking for 24 individuals from a single site."

Answered by AI

What are the eligibility requirements for participation in this trial?

"This clinical trial has a participant cap of 24 individuals, all of whom must possess oral neoplasms and be between the ages 21 and 89."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
The Oral Microbiome in OSCC
David R. Drake 2022. "The Oral Microbiome in OSCC". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04925700.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top